(2R)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrochromen-4-one

Details

Top
Internal ID 06dae488-b7d4-4b44-ad57-e1c12645f7ad
Taxonomy Phenylpropanoids and polyketides > Flavonoids > O-methylated flavonoids > 3-O-methylated flavonoids
IUPAC Name (2R)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrochromen-4-one
SMILES (Canonical) COC1=C(C=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O
SMILES (Isomeric) COC1=C(C=CC(=C1)[C@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)O
InChI InChI=1S/C16H14O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-6,13,17-19H,7H2,1H3/t13-/m1/s1
InChI Key FTODBIPDTXRIGS-CYBMUJFWSA-N
Popularity 8 references in papers

Physical and Chemical Properties

Top
Molecular Formula C16H14O6
Molecular Weight 302.28 g/mol
Exact Mass 302.07903816 g/mol
Topological Polar Surface Area (TPSA) 96.20 Ų
XlogP 2.40
Atomic LogP (AlogP) 2.52
H-Bond Acceptor 6
H-Bond Donor 3
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrochromen-4-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9028 90.28%
Caco-2 + 0.7003 70.03%
Blood Brain Barrier - 0.7500 75.00%
Human oral bioavailability - 0.8429 84.29%
Subcellular localzation Mitochondria 0.6551 65.51%
OATP2B1 inhibitior - 0.5983 59.83%
OATP1B1 inhibitior + 0.9576 95.76%
OATP1B3 inhibitior + 0.9701 97.01%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.7768 77.68%
P-glycoprotein inhibitior - 0.8694 86.94%
P-glycoprotein substrate - 0.9244 92.44%
CYP3A4 substrate + 0.5327 53.27%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7429 74.29%
CYP3A4 inhibition + 0.7959 79.59%
CYP2C9 inhibition + 0.8949 89.49%
CYP2C19 inhibition + 0.8994 89.94%
CYP2D6 inhibition + 0.6510 65.10%
CYP1A2 inhibition + 0.9106 91.06%
CYP2C8 inhibition - 0.5673 56.73%
CYP inhibitory promiscuity + 0.7998 79.98%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5775 57.75%
Eye corrosion - 0.9853 98.53%
Eye irritation + 0.9434 94.34%
Skin irritation - 0.6488 64.88%
Skin corrosion - 0.9295 92.95%
Ames mutagenesis - 0.6100 61.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6657 66.57%
Micronuclear + 0.8459 84.59%
Hepatotoxicity - 0.5718 57.18%
skin sensitisation - 0.9253 92.53%
Respiratory toxicity - 0.5333 53.33%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity + 0.7500 75.00%
Nephrotoxicity + 0.6028 60.28%
Acute Oral Toxicity (c) III 0.5979 59.79%
Estrogen receptor binding + 0.7548 75.48%
Androgen receptor binding + 0.5719 57.19%
Thyroid receptor binding + 0.6136 61.36%
Glucocorticoid receptor binding + 0.8489 84.89%
Aromatase binding + 0.5620 56.20%
PPAR gamma + 0.7521 75.21%
Honey bee toxicity - 0.8110 81.10%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.5700 57.00%
Fish aquatic toxicity + 0.7222 72.22%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL4878 Q16678 Cytochrome P450 1B1 240 nM
IC50
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.97% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.90% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.27% 95.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 91.74% 94.45%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 89.99% 85.14%
CHEMBL4208 P20618 Proteasome component C5 89.83% 90.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.79% 97.09%
CHEMBL2581 P07339 Cathepsin D 89.74% 98.95%
CHEMBL1806 P11388 DNA topoisomerase II alpha 89.59% 89.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 88.82% 99.23%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 88.10% 99.15%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 87.64% 94.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.30% 86.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.99% 95.89%
CHEMBL3194 P02766 Transthyretin 85.45% 90.71%
CHEMBL2535 P11166 Glucose transporter 85.07% 98.75%
CHEMBL3060 Q9Y345 Glycine transporter 2 84.26% 99.17%
CHEMBL1929 P47989 Xanthine dehydrogenase 82.27% 96.12%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 82.16% 97.14%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 81.51% 90.71%

Cross-Links

Top
PubChem 12310452
NPASS NPC140925
LOTUS LTS0041923
wikiData Q105001178